Relaxo Footwears Ltd Q1 FY27 Results Analysis: PAT Jumps 12.4%, Revenue Misses Goal
Cofacto Research
Updated August 14, 2026
2 min read
Positive
Relaxo Footwears Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 705.05 Cr (+7.73% YoY) and PAT growth of +12.35% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | August 13, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 705.05 Cr (+7.73% YoY) |
|---|
| PAT (Q1) | Rs. 54.94 Cr (+12.35% YoY) |
|---|
| EBITDA margin | 15.35% (+15 bps YoY) |
|---|
| EPS (Q1) | Rs. 2.21 (+12.76% YoY) |
|---|
| Market cap | Rs. 10,441.73 Cr |
|---|
| CMP | Rs. 419.45 |
|---|
Quarter Snapshot
Relaxo delivered 7.7% revenue growth and 12.4% PAT growth despite severe polymer cost pressure, aided by pricing power and a temporary inventory buffer that boosted margins. The GST cut and renewable energy SPV are structural tailwinds, but margin reversal from inventory normalization and elevated employee costs are near-term risks. Management's FY27 targets are on track, albeit with revenue slightly below the ~10% goal.
Key Investment Insights
Key Positives
- Revenue grew 7.73% YoY to Rs.705.05 Cr despite severe raw material headwinds.
- EBITDA margin expanded 15 bps YoY to 15.35%, defying expectations of compression.
- PAT grew 12.35% YoY to Rs.54.94 Cr.
- Price hikes of 15-18% were sustained without volume collapse, demonstrating pricing power.
- GST rate reduction (12% to 5%) improved competitive positioning versus unorganised sector.
- Renewable energy SPV incorporated to lower power costs for Haryana plants.
- Management strengthened with 10 new senior appointments across key functions.
Risk Factors
- Direct material consumption surged to 44.18% of revenue (+6.3pp YoY) due to polymer price spike from West Asia tensions.
- Employee benefits expense rose to 17.52% of revenue (+1.4pp YoY) due to permanent wage hike.
- Other expenses grew 19.26% YoY, faster than revenue, indicating cost pressure.
- Inventory build of Rs.99.25 Cr provided temporary margin benefit; reversal in Q2/Q3 could compress reported margins.
- Revenue growth of 7.73% is below management's ~10% FY27 target.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now